Literature DB >> 19175552

Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype.

Marco Lai1, Cinzia Grasso, Ilaria Boschi, Giuseppe D'Onofrio, Vincenzo Pascali, Giuseppe Leone.   

Abstract

BACKGROUND: Anti-D monoclonal antibody (MoAb) reagents have improved D typing in routine tests. However, they exhibit a wide range of reactivity with the weak D phenotype depending on the characteristics of the different MoAbs used. We analyzed the reactivity of immunoglobulin (IgM) anti-D by cluster analysis to characterize MoAb that have similar reactivities with the weak D phenotype. STUDY DESIGN AND METHODS: We used 36 consecutive samples with weak D phenotype in routine testing and determined their reactivity with different IgM and IgG anti-D MoAbs. The samples were characterized as belonging to a weak D type or category using commercial molecular biology kits.
RESULTS: The various anti-D MoAbs showed a wide grade of reactivity with the weak D samples. Similarities and dissimilarities in the behavior of the anti-D MoAbs with the weak D phenotype samples were detected with cluster analysis and the multidimensional scaling analysis. These analyses indicated different families of MoAbs characterized as having a high degree of homogeneity in their reactivity with the weak D phenotype. Between these MoAb families, the most effective at reacting with the weak D phenotype were RUM-1 and 175-2.
CONCLUSIONS: The results show that it is possible to classify the anti-D MoAbs on the basis of their reactivity with the weak D phenotype. This provides information about different MoAbs' properties on the basis of their belonging to a given of anti-D family.

Mesh:

Substances:

Year:  2009        PMID: 19175552     DOI: 10.1111/j.1537-2995.2008.02066.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  1 in total

1.  Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.

Authors:  Jelena Lukacevic Krstic; Slavica Dajak; Jasna Bingulac-Popovic; Vesna Dogic; Jela Mratinovic-Mikulandra
Journal:  J Clin Lab Anal       Date:  2017-06-26       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.